Mostrar el registro sencillo del ítem
dc.contributor.author | Oliver-Ferrándiz, María | es_ES |
dc.contributor.author | Milián, Lara | es_ES |
dc.contributor.author | Sancho-Tello, María | es_ES |
dc.contributor.author | Martín de Llano, José Javier | es_ES |
dc.contributor.author | Gisbert-Roca, Fernando | es_ES |
dc.contributor.author | Martínez-Ramos, Cristina | es_ES |
dc.contributor.author | Carda, Carmen | es_ES |
dc.contributor.author | Mata, Manuel | es_ES |
dc.date.accessioned | 2022-03-24T19:03:32Z | |
dc.date.available | 2022-03-24T19:03:32Z | |
dc.date.issued | 2021-07 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10251/181549 | |
dc.description.abstract | [EN] Matrix-assisted autologous chondrocyte implantation (MACI) has shown promising results for cartilage repair, combining cultured chondrocytes and hydrogels, including alginate. The ability of chondrocytes for MACI is limited by different factors including donor site morbidity, dedifferentiation, limited lifespan or poor proliferation in vitro. Mesenchymal stem cells could represent an alternative for cartilage regeneration. In this study, we propose a MACI scaffold consisting of a mixed alginate-agarose hydrogel in combination with human dental pulp stem cells (hDPSCs), suitable for cartilage regeneration. Scaffolds were characterized according to their rheological properties, and their histomorphometric and molecular biology results. Agarose significantly improved the biomechanical behavior of the alginate scaffolds. Large scaffolds were manufactured, and a homogeneous distribution of cells was observed within them. Although primary chondrocytes showed a greater capacity for chondrogenic differentiation, hDPSCs cultured in the scaffolds formed large aggregates of cells, acquired a rounded morphology and expressed high amounts of type II collagen and aggrecan. Cells cultured in the scaffolds expressed not only chondral matrix-related genes, but also remodeling proteins and chondrocyte differentiation factors. The degree of differentiation of cells was proportional to the number and size of the cell aggregates that were formed in the hydrogels. | es_ES |
dc.description.sponsorship | This work was funded by the Ministry of Economy and Competitiveness of the Spanish Government (PID2019-106099RB-C42, MM) and by the Generalitat Valenciana, Spain (PROMETEO/2020/069, CC). CIBER-BBN and CIBER-ER are financed by the VI National R&D&I Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and the Instituto de Salud Carlos III, with assistance of the European Regional Development Fund. | es_ES |
dc.language | Inglés | es_ES |
dc.publisher | MDPI AG | es_ES |
dc.relation.ispartof | Biomedicines | es_ES |
dc.rights | Reconocimiento (by) | es_ES |
dc.subject | Cartilage regeneration | es_ES |
dc.subject | HDPSCs | es_ES |
dc.subject | MACI | es_ES |
dc.subject | Alginate | es_ES |
dc.subject | Agarose | es_ES |
dc.subject | Chondrocyte | es_ES |
dc.subject | Tissue engineering | es_ES |
dc.title | Alginate-Agarose Hydrogels Improve the In Vitro Differentiation of Human Dental Pulp Stem Cells in Chondrocytes. A Histological Study | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.doi | 10.3390/biomedicines9070834 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-106099RB-C42/ES/MICROGELES BIOMIMETICOS PARA EL ESTUDIO DEL MICROENTORNO DEL TUMOR (TME) Y LA TRANSICION EPITELIO MESENQUIMA (EMT) EN CANCER DE PULMON/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//PID2019-106099RB-C42/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/GVA//PROMETEO%2F 2020%2F069/ | es_ES |
dc.rights.accessRights | Abierto | es_ES |
dc.description.bibliographicCitation | Oliver-Ferrándiz, M.; Milián, L.; Sancho-Tello, M.; Martín De Llano, JJ.; Gisbert-Roca, F.; Martínez-Ramos, C.; Carda, C.... (2021). Alginate-Agarose Hydrogels Improve the In Vitro Differentiation of Human Dental Pulp Stem Cells in Chondrocytes. A Histological Study. Biomedicines. 9(7):1-22. https://doi.org/10.3390/biomedicines9070834 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | https://doi.org/10.3390/biomedicines9070834 | es_ES |
dc.description.upvformatpinicio | 1 | es_ES |
dc.description.upvformatpfin | 22 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 9 | es_ES |
dc.description.issue | 7 | es_ES |
dc.identifier.eissn | 2227-9059 | es_ES |
dc.identifier.pmid | 34356898 | es_ES |
dc.identifier.pmcid | PMC8301309 | es_ES |
dc.relation.pasarela | S\443630 | es_ES |
dc.contributor.funder | Generalitat Valenciana | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.contributor.funder | European Regional Development Fund | es_ES |
dc.contributor.funder | Ministerio de Economía y Competitividad | es_ES |
dc.contributor.funder | Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina | es_ES |